Details for Patent: 9,757,552
✉ Email this page to a colleague
Which drugs does patent 9,757,552 protect, and when does it expire?
Patent 9,757,552 protects IMPLANON and NEXPLANON and is included in one NDA.
This patent has thirty-three patent family members in twenty-seven countries.
Summary for Patent: 9,757,552
| Title: | Applicator for inserting an implant |
| Abstract: | The invention pertains to an applicator (1) for inserting an implant, in particular a rod-like implant (2) containing an active substance, under the skin of a human or animal, comprising a housing (3), a cannula (6), a cannula holder (9), an implant (2) accommodated inside the cannula (6) and/or the cannula holder (9), a protective cover (7) for the cannula (6), and a mechanism (22, 23, 7) which, at least after the cover (7) has been removed from the cannula (6), secures the implant (2) inside the cannula (6) and/or cannula holder (9). The mechanism (22, 23, 7) disengages the implant (2) during insertion of the cannula (6) or after the cannula (6) has been inserted. Substantially no lateral force will be exerted during the expelling of the implant from the cannula. |
| Inventor(s): | Willem Jansen, Maurice Petrus Wilhelmus Tak, Hendricus Johannes Vertegaal, Iris Epkjen Hobo Van Der Graaf |
| Assignee: | Merck Sharp and Dohme BV |
| Application Number: | US11/795,805 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 9,757,552 |
|
Patent Claim Types: see list of patent claims | Use; Device; |
Drugs Protected by US Patent 9,757,552
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Organon | IMPLANON | etonogestrel | IMPLANT;IMPLANTATION | 021529-001 | Jul 17, 2006 | DISCN | No | No | 9,757,552 | ⤷ Start Trial | Y | PREVENTION OF PREGNANCY | ⤷ Start Trial | |||
| Organon | NEXPLANON | etonogestrel | IMPLANT;IMPLANTATION | 021529-002 | May 13, 2011 | RX | Yes | Yes | 9,757,552 | ⤷ Start Trial | Y | PREVENTION OF PREGNANCY | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 9,757,552
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| 05100418 | Jan 24, 2005 | |
| PCT Information | |||
| PCT Filed | January 20, 2006 | PCT Application Number: | PCT/EP2006/050346 |
| PCT Publication Date: | July 27, 2006 | PCT Publication Number: | WO2006/077250 |
International Family Members for US Patent 9,757,552
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 055716 | ⤷ Start Trial | |||
| Australia | 2006207455 | ⤷ Start Trial | |||
| Brazil | PI0607013 | ⤷ Start Trial | |||
| Canada | 2593849 | ⤷ Start Trial | |||
| China | 101151062 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
